Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue
Wellgistics Health (NASDAQ:WGRX) has announced a definitive agreement to acquire Peek Healthcare Technologies, operator of the Peek Meds Marketplace digital prescription shopping platform. The acquisition aims to expand Wellgistics' digital healthcare ecosystem and enhance prescription price transparency for consumers.
Peek's platform allows consumers to compare medication prices across local pharmacies, supporting over 2,500 patients with $1.5MM in annual revenue. The acquisition is expected to be immediately accretive to earnings and includes Peek's consulting division, which assists drug manufacturers with Market Access, Branding, and Commercialization services.
The strategic move comes as U.S. retail prescription drug spending is forecasted to increase by over 40% in the next decade. Post-acquisition, Peek will operate as a wholly-owned subsidiary of Wellgistics Health while maintaining its brand identity.
Wellgistics Health (NASDAQ:WGRX) ha annunciato un accordo definitivo per acquisire Peek Healthcare Technologies, operatore della piattaforma digitale di shopping per prescrizioni Peek Meds Marketplace. L'acquisizione mira a espandere l'ecosistema sanitario digitale di Wellgistics e migliorare la trasparenza dei prezzi delle prescrizioni per i consumatori.
La piattaforma di Peek consente ai consumatori di confrontare i prezzi dei farmaci tra le farmacie locali, supportando oltre 2.500 pazienti con un fatturato annuo di 1,5 milioni di dollari. Si prevede che l'acquisizione sarà immediatamente accrescitiva per gli utili e include la divisione di consulenza di Peek, che assiste i produttori di farmaci con servizi di Accesso al Mercato, Branding e Commercializzazione.
Questa mossa strategica arriva mentre si prevede che la spesa per i farmaci da prescrizione al dettaglio negli Stati Uniti aumenterà di oltre il 40% nel prossimo decennio. Dopo l'acquisizione, Peek opererà come una controllata interamente posseduta da Wellgistics Health, mantenendo la propria identità di marca.
Wellgistics Health (NASDAQ:WGRX) ha anunciado un acuerdo definitivo para adquirir Peek Healthcare Technologies, operador de la plataforma digital de compras de recetas Peek Meds Marketplace. La adquisición tiene como objetivo expandir el ecosistema de salud digital de Wellgistics y mejorar la transparencia de precios de las recetas para los consumidores.
La plataforma de Peek permite a los consumidores comparar precios de medicamentos en farmacias locales, apoyando a más de 2,500 pacientes con $1.5 millones en ingresos anuales. Se espera que la adquisición sea inmediatamente accretiva a las ganancias e incluye la división de consultoría de Peek, que asiste a los fabricantes de medicamentos con servicios de Acceso al Mercado, Branding y Comercialización.
Este movimiento estratégico se produce mientras se prevé que el gasto en medicamentos recetados al por menor en EE. UU. aumente más del 40% en la próxima década. Después de la adquisición, Peek operará como una subsidiaria de propiedad total de Wellgistics Health, manteniendo su identidad de marca.
Wellgistics Health (NASDAQ:WGRX)는 Peek Healthcare Technologies를 인수하기 위한 최종 계약을 발표했습니다. Peek Meds Marketplace 디지털 처방 쇼핑 플랫폼의 운영자입니다. 이 인수는 Wellgistics의 디지털 의료 생태계를 확장하고 소비자를 위한 처방 가격 투명성을 향상시키는 것을 목표로 하고 있습니다.
Peek의 플랫폼은 소비자가 지역 약국 간의 약물 가격을 비교할 수 있도록 하여 연간 150만 달러의 수익을 올리는 2,500명 이상의 환자를 지원합니다. 이 인수는 즉각적으로 수익을 증가시킬 것으로 예상되며, 시장 접근, 브랜딩 및 상업화 서비스를 통해 제약 제조사를 지원하는 Peek의 컨설팅 부서도 포함됩니다.
이 전략적 조치는 미국의 소매 처방약 지출이 향후 10년 동안 40% 이상 증가할 것으로 예상되는 가운데 이루어졌습니다. 인수 후, Peek는 Wellgistics Health의 완전 소유 자회사로 운영되며 브랜드 정체성을 유지합니다.
Wellgistics Health (NASDAQ:WGRX) a annoncé un accord définitif pour acquérir Peek Healthcare Technologies, opérateur de la plateforme de shopping numérique pour prescriptions Peek Meds Marketplace. L'acquisition vise à étendre l'écosystème de santé numérique de Wellgistics et à améliorer la transparence des prix des prescriptions pour les consommateurs.
La plateforme de Peek permet aux consommateurs de comparer les prix des médicaments dans les pharmacies locales, soutenant plus de 2 500 patients avec 1,5 million de dollars de revenus annuels. L'acquisition devrait être immédiatement bénéfique pour les bénéfices et inclut la division de conseil de Peek, qui aide les fabricants de médicaments avec des services d'accès au marché, de branding et de commercialisation.
Cette démarche stratégique intervient alors que les dépenses en médicaments sur ordonnance au détail aux États-Unis devraient augmenter de plus de 40 % au cours de la prochaine décennie. Après l'acquisition, Peek fonctionnera comme une filiale entièrement détenue de Wellgistics Health tout en conservant son identité de marque.
Wellgistics Health (NASDAQ:WGRX) hat eine endgültige Vereinbarung zur Übernahme von Peek Healthcare Technologies bekannt gegeben, dem Betreiber der digitalen Rezeptshopping-Plattform Peek Meds Marketplace. Die Übernahme zielt darauf ab, das digitale Gesundheitsökosystem von Wellgistics zu erweitern und die Pretransparenz von Rezepten für die Verbraucher zu verbessern.
Die Plattform von Peek ermöglicht es den Verbrauchern, Medikamentenpreise in lokalen Apotheken zu vergleichen und unterstützt über 2.500 Patienten mit einem Jahresumsatz von 1,5 Millionen Dollar. Die Übernahme wird voraussichtlich sofort gewinnbringend sein und umfasst Peeks Beratungsabteilung, die Arzneimittelhersteller mit Dienstleistungen zu Marktzugang, Branding und Kommerzialisierung unterstützt.
Dieser strategische Schritt erfolgt, während die Ausgaben für rezeptpflichtige Medikamente im Einzelhandel in den USA voraussichtlich in den nächsten zehn Jahren um über 40% steigen werden. Nach der Übernahme wird Peek als hundertprozentige Tochtergesellschaft von Wellgistics Health operieren und dabei seine Markenidentität beibehalten.
- Immediately accretive to earnings
- Adds $1.5MM annual revenue stream
- Expands service offering with digital prescription platform
- Gains consulting division for pharmaceutical manufacturers
- Positions for 40% market growth in prescription spending
- Acquisition costs and terms not disclosed
- Integration risks with existing operations
- Relatively small current patient base of 2,500
Insights
Wellgistics Health's acquisition of Peek Healthcare Technologies represents a strategic move that appears immediately accretive to earnings while expanding the company's footprint in prescription price transparency services. With Peek's
The deal strategically positions Wellgistics to capitalize on regulatory tailwinds from the Consolidated Appropriations Act of 2021, which mandates prescription drug price transparency. This acquisition enhances Wellgistics' competitive positioning by adding a complementary digital platform to its existing distribution and services framework, creating a more vertically integrated healthcare technology ecosystem.
What's particularly compelling is Peek's dual-revenue model combining the consumer-facing marketplace with a consulting division for pharmaceutical manufacturers. This diversified approach provides Wellgistics multiple growth vectors and potential cross-selling opportunities between business segments. The addition of Peek's market access, branding, and commercialization services creates synergies with Wellgistics' trade and distribution capabilities, potentially driving higher-margin consulting revenue.
While specific acquisition terms weren't disclosed, the strategic rationale appears sound as U.S. retail prescription drug spending is projected to increase by
TAMPA, FL / ACCESS Newswire / April 10, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced it has entered into a definitive agreement to acquire Peek Healthcare Technologies, Inc. ("Peek"). Peek operates the Peek Meds Marketplace, a digital prescription shopping platform built to empower consumers with real-time pricing transparency to assist consumers with making more informed medication purchase decisions.
Through this acquisition, Wellgistics Health intends to expand its digital healthcare ecosystem and further its mission to create a more affordable, accessible, and patient-centric prescription experience.
"Access to clear and transparent medication pricing should be a right, not a privilege," said Brian Norton, Chief Executive Officer of Wellgistics Health. "The Peek platform aligns with our mission and vision to reimagine healthcare delivery - giving consumers the transparency, choice, and control they deserve. When combined with our existing technology stack, we are bringing a comprehensive set of solutions to market aimed at enhancing value and mitigating unnecessary costs across the prescription journey for other relevant stakeholders."
Peek represents a high-growth opportunity within the evolving healthcare technology landscape, as per capita U.S. retail prescription drug spending is forecasted to increase by more than
In addition to its Marketplace platform, Peek also operates a full consulting division dedicated to assisting brand-name and specialty-lite drug manufacturers in navigating the three major building blocks essential for successful market entry: Market Access, Branding, and Commercialization. This strategic advisory arm of Peek will now be further complemented by Wellgistics Health's capabilities, adding a fourth critical pillar - Trade, Distribution, and Pharmacy Services - thereby delivering a fully integrated suite of commercialization services for pharmaceutical manufacturers.
"Peek was founded on the principle that every patient deserves to shop for prescriptions with confidence and clarity," said Michael Navin, Chief Executive Officer and Founder of Peek. "Partnering with Wellgistics Health allows us to not only scale our consumer offerings but also strengthen our value proposition to pharmaceutical manufacturers by combining best-in-class market access, branding, commercialization, and now full trade and distribution support."
The Peek Meds Marketplace is designed to enhance members' existing benefit plans by providing a robust platform that delivers clear medication pricing information from local pharmacies, allowing consumers to compare prescription costs and find the lowest price.
Upon completion of the transaction, Peek will operate as a wholly-owned subsidiary of Wellgistics Health, maintaining its brand identity while gaining access to an expanded infrastructure, technology resources, and strategic pharmacy relationships.
This acquisition represents a key step in Wellgistics Health's broader strategy to combine supply chain expertise with digital consumer tools, driving forward toward a future where affordable, transparent, and patient-first healthcare becomes the new standard.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is a holding company for existing and future planned operating companies centered around healthcare technology and pharmaceutical services. It seeks to be a micro health ecosystem, with a portfolio of companies consisting of a technology platform, pharmacy, and wholesale operations that provide novel prescription hub and clinical services. Wellgistics Health is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. With the successful integration of its patient-centric approach and innovative healthcare applications, Wellgistics Health intends to shift the dynamic of pharmaceutical care to revolve around the patient for a wide range of therapeutic conditions by offering a full spectrum of integrated solutions as a result of leveraging the synergies of its business segments to address access, care coordination, dispensing, delivery, and clinical management of pharmaceutical products ranging from "specialty-lite" to general maintenance conditions. For more information, please visit the Company's website: https://wellgisticshealth.com/
About Peek
Peek is a pioneering digital prescription platform transforming how patients shop for medications. Serving both employer groups and soon direct-to-consumer markets, Peek's mission is to empower individuals with price transparency, innovative comparison tools, and seamless access to affordable prescriptions nationwide. For more information, please visit the Peek website: https://peekmeds.com/
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may", "will", "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the "Risk Factors" section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the expected revenue contribution from Peek Healthcare to WGRX's business?
How will the Peek acquisition impact WGRX's earnings?
What services does Peek Healthcare bring to WGRX's portfolio?
What is the market growth potential for WGRX's prescription services?
How will Peek operate after the WGRX acquisition?
